Grant Opportunities

NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)

By Super UserJuly 22, 2013No Comments

Home » NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)

…

Funding Opportunity Number:	PAR-13-278
Opportunity Category:	Discretionary
Funding Instrument Type:	Cooperative Agreement
Category of Funding Activity:	Health
CFDA Number:	93.583
Eligible Applicants	State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name:	HHS-NIH11
Closing Date:	Sep 07, 2016
Award Ceiling:
Expected Number of Awards:
Creation Date:	Jul 22, 2013
Funding Opportunity Description:	The purpose of this Funding Opportunity Announcement (FOA) is to provide a vehicle for submitting grant applications to conduct multi-site, randomized, controlled, Phase 3 clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials may address questions within the mission and research interests of the NINDS. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/).

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=238034

{iframe}http://grants.nih.gov/grants/guide/pa-files/PAR-13-278.html{/iframe}

Leave a Reply Cancel Reply

© 2024 BioHealth Innovation.